On ECHEMI
Home > Drugs > SPH NO.1 Biochemical & Pharmaceutical Co., Ltd.
SPH NO.1 Biochemical & Pharmaceutical Co., Ltd.
  • Founded in:

    1994-07-30
  • Country:

    China China
  • Address:

    No. 1317, Jianchuan Road, Minhang District, Shanghai
  • Tax NO.:

    91310112133747458R
  • Registered Funds:

    323.8 million yuan
  • Website:

  • Email:

Related Drugs
Ranitidine Hydrochloride Injection
The main ingredient of this product is: Ranitidine hydrochloride. Its chemical name is: Nprime;-methyl-N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]-methyl]thio]ethyl]-2-nitro-1,1-ethylenediamine hydrochloride. Structural formula: (see Ranitidine hydrochloride capsules) Molecular formula: C13H22N4O3SHCl Molecular weight: 350.87
Name Description Content CAS NO. Registered Holders
Ranitidine Hydrochloride

This product is an H2 receptor antagonist. It replaces the imidazole ring of cimetidine with a furan ring. It has a higher selectivity for H2 receptors and can significantly inhibit the basal and nocturnal gastric acid secretion of normal people and ulcer patients, as well as the gastric acid secretion caused by pentagastrin, histamine and meals. Its potency in inhibiting gastric acid secretion is 5 to 12 times that of cimetidine in terms of moles. Intravenous injection of this product can reduce gastric acid secretion by 90%; it has a certain inhibitory effect on the secretion of pepsinogen. It has a protective effect on experimental gastric mucosal damage and acute ulcers. It has no effect on the secretion of gastrin and sex hormones.

More

This product is an H2 receptor antagonist. It replaces the imidazole ring of cimetidine with a furan ring. It has a higher selectivity for H2 receptors and can significantly inhibit the basal and nocturnal gastric acid secretion of normal people and ulcer patients, as well as the gastric acid secretion caused by pentagastrin, histamine and meals. Its potency in inhibiting gastric acid secretion is 5 to 12 times that of cimetidine in terms of moles. Intravenous injection of this product can reduce gastric acid secretion by 90%; it has a certain inhibitory effect on the secretion of pepsinogen. It has a protective effect on experimental gastric mucosal damage and acute ulcers. It has no effect on the secretion of gastrin and sex hormones.

66357-59-3 48
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.